Pfizer plans on acquiring the Mylan Pharmaceuticals
Pfizer said it will consolidate its off-patent medication unit Upjohn with Mylan, a $10 billion nonexclusive pharmaceutical organization, to make another business with its very own off-patent marked and conventional medication lines. Pfizer and GlaxoSmithKline Plc (GSK.L) said in December…